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Abstract
Background: Depressive symptoms, and the associated coexistence of symptoms of anxiety and decreased quality of life (QoL),
are common in patients with heart failure (HF). However, treatment strategies for depressive symptoms in patients with HF still
remain to be established. Internet-based cognitive behavioral therapy (ICBT), as guided self-help CBT programs, has shown good
effects in the treatment of depression. Until now, ICBT has not been evaluated in patients with HF with depressive symptoms.
Objective: The aims of this study were to (1) evaluate the effect of a 9-week guided ICBT program on depressive symptoms
in patients with HF; (2) investigate the effect of the ICBT program on cardiac anxiety and QoL; and (3) assess factors associated
with the change in depressive symptoms.
Methods: Fifty participants were randomized into 2 treatment arms: ICBT or a Web-based moderated discussion forum (DF).
The Patient Health Questionnaire-9 was used to measure depressive symptoms, the Cardiac Anxiety Questionnaire (CAQ) was
used to measure cardiac-related anxiety, and the Minnesota Living with Heart Failure questionnaire was used to measure QoL.
Data were collected at baseline and at follow-up at the end of the 9-week intervention. Intention-to-treat analysis was used, and
missing data were imputed by the Expectation-Maximization method. Between-group differences were determined by analysis
of covariance with control for baseline score and regression to the mean.
Results: No significant difference in depressive symptoms between the ICBT and the DF group at the follow-up was found,
[F(1,47)=1.63, P=.21] and Cohen´s d=0.26. Secondary within-group analysis of depressive symptoms showed that such symptoms
decreased significantly in the ICBT group from baseline to the follow-up (baseline M=10.8, standard deviation [SD]=5.7 vs
follow-up M=8.6, SD=4.6, t(24)=2.6, P=.02, Cohen´s d=0.43), whereas in the DF group, there was no significant change (baseline
M=10.6, SD=5.0, vs follow-up M=9.8, SD=4.3, t(24)=0.93, P=.36. Cohen´s d=0.18). With regard to CAQ and QoL no significant
differences were found between the groups (CAQ [d(1,47)=0.5, P=.48] and QoL [F(1,47)=2.87, P=.09]). In the ICBT group in
the CAQ subscale of fear, a significant within-group decrease was shown (baseline M=1.55 vs follow-up M=1.35, P=.04). In the
ICBT group, the number of logins to the Web portal correlated significantly with improvement in depressive symptoms (P=.02),
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whereas higher age (P=.01) and male sex (P=.048) were associated with less change in depressive symptoms. This study is
underpowered because of difficulties in the recruitment of patients.
Conclusions: Guided ICBT adapted for persons with HF and depressive symptoms was not statistically superior to participation
in a Web-based DF. However, within the ICBT group, a statically significant improvement of depressive symptoms was detected.
ClinicalTrial: Clinicaltrials.gov NCT01681771; https://clinicaltrials.gov/ct2/show/NCT01681771 (Archived by WebCite at
http://www.webcitation.org/6ikzbcuLN)
(J Med Internet Res 2016;18(8):e194)   doi:10.2196/jmir.5556
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Introduction
Depressive symptoms are common in patients with heart failure
(HF), affecting about 20%-40% of the HF population [1-3].
They lead to higher morbidity and mortality and diminish
self-care and health-related quality of life (QoL) [3]. However,
treatment strategies for depressive symptoms in patients with
HF still remain to be established [3,4].
HF has an unpredictable trajectory with disturbing and limiting
symptoms that frequently change, leading to a shift between
good and bad days [5] and with a constant risk of hospitalization
or death [6,7]. Patients with HF may therefore be prone to
developing negative thoughts, rumination, and feelings of
hopelessness about loss of health and independence and an
uncertain future [8], and this can lead to the development of
depression.[9,10]. A vast majority of patients with HF and
depressive symptoms also have symptoms of anxiety [11].
Depressive symptoms have a strong negative impact on QoL
in patients with HF [3,4]. Because anxiety and depression are
closely related, an intervention focusing on decreasing
depression may also improve symptoms of anxiety and increase
QoL. In general, depressive symptoms can be treated, either by
psychotherapy or by pharmacology [12]. However, the impact
of pharmacological treatment of depression in HF is not clear
[4] and may be complicated due to an already complex
pharmacological treatment regime [2]. Furthermore, patients
with heart disease seem to prefer talking therapies such as
cognitive behavioral therapy (CBT) over pharmacological
treatment [8].
In CBT, patients become active participants in their treatment
and perform tasks to become aware of and to modify negative
thoughts and unhelpful behaviors. By developing skills to cope
with these negative thoughts and behaviors, CBT also
contributes to a decrease of negative emotions [13]. In HF
patients, Freedland et al [14] demonstrated that undergoing CBT
for 6 months decreased depression and Gary et al [15] found
CBT to be beneficial, especially when combined with physical
exercise. In these studies, CBT was provided face-to-face. Due
to the lack of CBT therapists to deliver such face-to-face CBT,
combined with the large number of HF patients with depression,
most HF patients with depressive symptoms might not get access
to CBT. Internet-based cognitive behavioral therapy (ICBT)
may be an alternative to face-to-face CBT. ICBT has been
shown to be a good and time-efficient method for the treatment
of depressive symptoms and also effective when delivered by
professionals other than psychotherapists. ICBT might,
therefore, be considered as an attractive treatment strategy for
depression in HF [16], but this is an area still waiting to be
explored. Furthermore, since the frequency of participation in
CBT treatment [17], level of depressive symptoms
pre-intervention [18], age [19], sex, and New York Heart
Association Class (NYHA class) [2] may impact changes in
depressive symptoms, it is important to investigate these factors
in intervention programs.
Recently our group showed that an ICBT program designed for
HF patients was feasible [20], but the effect of ICBT on
depressive symptoms in patients with HF has, to our knowledge,
not been tested in a randomized controlled trial. The primary
aim of this study was therefore to evaluate the short-term effect
of ICBT on depressive symptoms in patients with HF. A second
aim was to investigate the effect of the ICBT program on cardiac
anxiety and QoL (secondary outcomes). A third aim was to
assess these factors’ associations with the change in depressive
symptoms.
Methods
Design
An open label, randomized control design was used.
Recruitment Procedure and Inclusion
To recruit participants, an information letter was sent to all
patients who had an outpatient appointment or who had been
admitted to hospital with the main diagnosis of HF during 2013
and 2014 in 4 hospitals in the southeast of Sweden (Figure 1).
Inclusion criteria were at least mild depressive symptoms (the
Patient Health Questionnaire-9 (PHQ-9)≥5), regular access to
a computer with an Internet connection, access to a cellphone,
being motivated to participate in treatment of depressive
symptoms, and being aged older than 18 years. Exclusion criteria
were suffering from other severe disease or illness that hindered
participation in the study, admission to hospital during the last
month due to HF, other treatment planned during the
intervention that had been assessed as likely to hinder
participation (such as surgery or planned inpatient treatment),
severe level of depressive symptoms assessed as needing
inpatient treatment, and high level of suicide risk or other
psychiatric disorder assessed as making the intervention
unsuitable. Patients who had perceived themselves as depressed
or feeling down during (at least) the last 2 weeks and felt
motivated and ready to participate in the study were invited to
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register their interest and perform a Web-based screening on
the study website. Computer/Internet literacy was not a criterion
for inclusion or exclusion. However, recipients interested in
participation had to register on the study website and complete
a Web-based screening form including an assessment of
depressive symptoms by means of the PHQ-9, self-reported use
of medication, comorbidities, NYHA class, and demographics.
A total of 64 patients completed the Web-based screening form
and 58 were found to be possible candidates for inclusion.
Candidates were contacted by telephone to check any
uncertainties in the screening forms and to prevent multiple
registrations. A structured phone assessment using the Mini
International Neuropsychiatric Interview Swedish revised
version 5.0.0 [21] was conducted to detect symptoms of other
psychiatric health problems or suicidality that could hinder
participation in the intervention, as shown in Figure 1. Two
candidates were excluded because of suspicion of other mental
illness and 3 candidates were excluded because they reported
no depressive symptoms during the phone interview despite a
screening PHQ-9 >4. During the phone call, the participant
received detailed information about the study procedures. The
50 patients remaining after the telephone interview underwent
baseline assessment and were randomized to either the ICBT
group or the discussion forum group (DF group). Randomization
was performed by a person blinded to screening and baseline
data using Stata v.13 proc Ralloc with a block size of two. All
participants gave written informed consent. No financial
compensation was given to the participants. The regional ethical
review board in Linköping, Sweden approved the study (dnr
2011/166-31). The study is registered at clinicaltrials.gov
(NCT01681771).
Figure 1. Flow diagram of participants. DF, discussion forum; HF, heart failure; ICBT, Internet-based cognitive behavioral therapy; PHQ-9, Patient
Health Questionnaire-9.
Intervention Procedure
Each participant received a password and a user name. Login
to the Web portal (to access the treatment program, feedback,
secure email, and assessment forms) required a 2-factor
authentication system (requiring both a user name and password
login and a single use code sent to a preregistered mobile phone)
to protect sensitive information. If technical problems occurred,
both the therapist and the participants could get support from a
computer technician.
The ICBT program has been described in detail elsewhere [20].
Compared with the ICBT program tested in the proof-of-concept
study and based on the findings that many of the participants
in proof-of-concept study reported that the intervention was
quite demanding in some parts, a short nonmandatory relaxation
exercise was added in module 3. No changes were made to the
program during the trial. To summarize, the ICBT program
consisted of 7 consecutive modules that were worked with over
9 weeks (Table 1). Each module contained texts to be read and
assignments to be completed by the participants. Written
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feedback was provided on each assignment. Participants could
ask questions about the feedback or the content of the module
using the secure email system. A mental health specialist nurse
with experience of HF care provided feedback and answers
within 24 hours during weekdays. The mental health nurse was
supervised by a clinical psychologist and could consult a
cardiologist and nurses specializing in HF care if needed.
Participants who did not complete modules were reminded by
personalized manually written emails, a maximum of 3
reminders were sent during a consecutive period of 2 weeks.
Screenshots from different parts of the treatment platform are
available (Multimedia Appendix 1), and a more comprehensive
tour of the platform is available (Multimedia Appendix 2).
Patients who were randomized to the DF group participated in
a moderated discussion Web-based forum where new discussion
topics were presented each week over a 9-week period. The
topic was introduced without any extended background in a
presentation consisting of statements and questions (Table 1).
The discussion was performed in writing. Participants made
their posts in discussion threads for each topic. To minimize
waiting time, the participants in the DF group were allocated
to 2 groups (n=12 and n=13) based on the dates they were
enrolled in the study. All participants in the DF group were
offered ICBT after the completion of the study.
Table 1. Overview of the guided Internet-based cognitive behavioral therapy program and the discussion forum.
WeekDFc (topic/question for discussion)ICBTa (content and CBTb component)Module
1HFd: what do you know about HF?Introduction (values and goals)1
2The effect of HF on everyday life: do you have any tips
you would like to share about handling HF?
Living with
heart failure (psychoeducation)
2
3Self-care: do you have any methods that make self-care
easier that you can share with the others in the DF?
Depression/depressive symptoms and heart failure (psy-
choeducation)
Nonmandatory relaxation exercise
3
4Physical activity: have you been recommended physical
activity? What is good or bad about physical activity when
suffering from HF?
Behavior activation 1: to enable change4
5Health care contacts: do you prepare yourself before
health care appointments? Do you have any tips you can
share with the others?
6Health literacy: if you do not get answers from the health
care system, do you look for information in other ways?
Do you have any tips on where one can find information
about health and diseases such as HF and depression?
Behavior activation 2: to implement change5
7The effect of HF and depression on significant others: do
you think that your health affects your relationships with
others? If so, in what ways?
8The effect of HF and depression on significant others:
how do you handle situations where your health affects
other? Do you have any good examples of how to handle
this that you can share?
Problem solving: a tool for dealing with problems6
9Summarizing: are there questions/topics that have not
been discussed that you would like to address? How did
you perceive the DF?
Consummation7
aICBT: Internet-based cognitive behavioral therapy.
bCBT:cognitive behavioral therapy.
cDF:discussion forum.
dHF:heart failure.
Measurements
Self-assessed data were collected on the Web at baseline (before
the start of the intervention) and after the end of week 9 in the
intervention. The data collection system for the follow-up was
accessible for the participants from the 63rd day after the start
of the intervention and could be completed during a 3-week
period. All data except activity in the program was self-reported.
Participants who did not complete outcome measures were
reminded to do so by email up to 3 times.
Depressive Symptoms (Primary Outcome
Measurement)
Depressive symptoms were measured with the self-administered
PHQ-9 [22]. The PHQ-9 is a 9-item instrument for measurement
of depressive symptoms during the previous 2 weeks. Each item
is answered on a 4-grade scale where zero means that the item
does not affect the person, and scores 1 to 3 indicate that the
item affects the person for periods ranging from several days
to almost every day. The answers are summed to a total sum
score in the range 0-27, with higher numbers representing a
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higher level of depressive symptoms. Proposed cutoff values
are 0-4 for no depressive symptom, 5-9 for mild depression,
10-14 for moderate depression, 15-19 for moderately severe
depression, and 20-27 for severe depression [23]. PHQ-9 has
been tested for reliability and validity in patients with HF [24].
The Web-based version of PHQ-9 has demonstrated good
interformat reliability [25]. Cronbach’s alpha of the PHQ-9 in
this study was .81 (baseline) and .82 (follow-up).
Cardiac Anxiety (Secondary Outcome Measurement)
The Cardiac Anxiety Questionnaire (CAQ) [26] was used to
measure cardiac-related anxiety. CAQ is an 18-item self-rating
instrument. Item scores range from 0 (never) to 4 (always). The
total sum and mean total (range from 0 to 4) can be calculated
for CAQ. The CAQ consists of 3 subscales: fear, avoidance,
and heart-focused attention. CAQ has demonstrated good
psychometric properties [26]. Cronbach’s alpha of the CAQ in
this study was total scale .87 (baseline) and .85 (follow-up);
subscale of fear .83 and .80; subscale of avoidance .89 and .88;
subscale of heart-focused attention .69 and .70.
QoL (Secondary Outcome Measurement)
QoL was measured with the disease-specific instrument
Minnesota Living with Heart Failure questionnaire (MLHF)
[27]. MLHF is a 21-item self-rating instrument. Each item is
scored on a 6-point Likert scale (no, 0 to very much, 5). The
total score is in the range 0-105, and a lower score indicates
better QoL. The MLHF can be divided into physical and
emotional factors. The reliability of MLHF has been reported
as good [28,29]. A change of 5 points has been suggested as
clinically important [30], Cronbach’s alpha of the MLHF in this
study was total score .93 (baseline) and .93 (follow-up); physical
.91 and .90; emotional .93 and .92.
Activity in the ICBT Program
Activity in the program was calculated by the number of
modules that the participants worked with (ie, the module had
been assigned to the participant and the participant had done
some activity related to the module, eg, handed in an assignment
or posted messages regarding the module to the feedback
provider; ICBT group only) as well as the number of logins to
the Web portal during the 9-week period (both groups). Data
concerning activity was aggregated from the Web portals log.
Statistical Methods and Power Analysis
Analysis of participants’ characteristics was performed with
descriptive statistics (mean, standard deviation, percent, and
frequencies). For continuous variables, assumptions of normality
were checked and primary outcome measurements were found
suitable for parametric analysis. Analysis of covariance
(ANCOVA) adjusting for baseline scores and regression to the
mean [31] was used for comparison between groups (ie, ICBT
vs DF). Paired samples t tests were used for within-group
comparisons. Effect size was calculated with Cohen´s d. A small
effect is considered to be between 0.2 and .0.5, a medium effect
is considered between 0.5 and 0.8, and a value above 0.8 is
considered to be a large effect. Pearson`s r or Kendall´s tau-b
were used to analyze associations with change in the level of
depressive symptoms. A chi-square test was used for nominal
data, and if the expected number of observations was less than
5, Fisher´s exact test was used. Subtracting the baseline sum
from the follow-up sum gave a figure indicating the change in
level of depressive symptoms. A negative value meant a
decrease of depressive symptoms, whereas a positive value
meant an increase of depressive symptoms at the follow-up
compared with baseline. All analyses were performed according
to the intention-to-treat principle, regardless of actual completion
of the ICBT program or DF.
A total of 18% (n=9) of the participants had missing data at the
follow-up measurement. Missing values analysis was performed
and data missing completely at random was assumed because
there were no significant differences between background
variables for participants with complete data versus incomplete
data, and Little´s test for missing completely at random was not
significant (χ2(111, N=50)=82.07, P=.98). Missing values were
imputed using the Expectation-Maximization (EM) method.
Based on observed values, EM imputes missing values based
on maximum likelihood estimates in an iterative process [32].
Subgroup analysis was performed on participants with complete
data. Power analysis showed that a total of 104 participants
were needed (effect size=0.5, alpha=.05 (Z=1.96), power 0.80
(Z −0.84). Statistical analysis was performed using IBM SPSS,
version 23 and Microsoft Excel 2013. P value <.05 was
considered as significant.
Results
The characteristics of the participants are presented in (Table
2). Most (n=29, 59%) of the participants were men, and the
mean age was 63 years (range 23-80). Participants in the DF
group reported significantly more prescription of diuretics (χ2(1,
N = 50)=4.67, P=.03) and sleep medications (χ2(1, N=50)=3.95,
P=.047). Participants who did not complete the follow-up
assessment (n=9) did not significantly differ at baseline in level
of depression (PHQ-9 t (48)=1.89, P=.07), cardiac-related
anxiety (CAQ t (48)=-0.55, P=.60), or QoL (MLHF t (48)=0.69,
P=.50) from those who completed the assessment.
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Table 2. Participants’ characteristics.
DF group (n=25)ICBT group (n=25)Total (n=50)
Demographics
62.3 (11.7)63.6 (13.9)62.9 (12.8)Age, M (SD)
14 (58)15 (60)29 (59)Men, n (%)
18 (75)19 (76)37 (76)Cohabitationa, n (%)
11.2 (5.2)11.8 (4.4)11.5 (4.8)Level of depression at screening PHQ-9, M
(SD)
HFbsymptoms and treatment
NYHAc class, n (%)
3 (12)8 (32)11 (22)I
8 (32)12 (48)20 (40)II
13 (52)5 (20)18 (36)III
1 (4)0 (0)1 (2)IV
23 (92)24 (96)48 (96)Dyspnead, n (%)
24 (96)25 (100)49 (98)Fatigued, n (%)
12 (48)14 (56)23 (46)Swollen legs or feetd, n (%)
23/2 (92/8)22/3 (88/12)45/5 (88/10)Time with HF>6 month/<6 month, n (%)
19 (76)17 (68)36 (72)Previously hospitalized due to HF, n (%)
22 (88)22 (88)44 (88)Beta blocker, n (%)
25 (100)22 (88)47 (94)ACE-Ie/ARBf, n (%)
20 (80)g14 (56)34 (68)Diuretics, n (%)
Comorbidities, n (%)
10 (40)8 (32)18 (36)Ischemic heart disease
15 (60)11 (44)26 (52)Hypertension
12 (48)14 (56)26 (52)Arrhythmia
5 (20)2 (8)7 (14)Diabetes
5 (20)1 (4)6 (12)Pulmonary disease
7 (28)4 (16)11 (22)Stroke or TIA
0 (0)1 (4)1 (2)Kidney disease
2 (8)3 (12)5 (10)Cancer
0 (0)2 (8)2 (4)Other psychiatric disorderh
Pharmacological antidepressive, anxiolytic, or sleep medication
6 (24)9 (12)9 (18)Antidepressives
1 (4)1 (4)2 (4)Anxiolytics
10 (40)g4 (16)14 (28)Sleep medication
aCohabitation includes participants that live with someone in a long-term relationship (including married). Not living with partner includes participants
who were divorced, with partner deceased or living alone.
bHF, heart failure.
cNYHA, New York Heart Association.
dSymptoms reported to affect the participant very severely to little have been collapsed and reported as presence of symptoms.
eACE-I, angiotensinogen-converting enzyme inhibitor.
fARB, angiotensin receptor blocker.
gSignificant difference between CBT and discussion groups (P<.05).
J Med Internet Res 2016 | vol. 18 | iss. 8 | e194 | p.6http://www.jmir.org/2016/8/e194/
(page number not for citation purposes)
Lundgren et alJOURNAL OF MEDICAL INTERNET RESEARCH
XSL•FO
RenderX
hSelf-reported: anxiety disorder (n=1) and drug dependence (n=1).
Primary Outcome: Level of Depressive Symptoms
In the primary ANCOVA analysis, there was no significant
difference in depressive symptoms between the ICBT and the
DF group at the follow-up [F (1,47)=1.63, P=.21] Cohen´s d=
0.26. Secondary within-group analysis showed that depressive
symptoms in patients in the ICBT group decreased significantly
from baseline to the follow-up (Figure 2) (baseline M = 10.8,
SD=5.7 vs follow-up M=8.6, SD=4.6, t (24)=2.6, P=.02.
Cohen´s d=0.43). In the patients in the DF group, a small
nonsignificant change in depressive symptoms was found
(baseline M = 10.6, SD=5.0, vs follow-up M = 9.8, SD=4.3, t
(24)=0.93, P=.36. Cohen´s d= 0.18).
Figure 2. Mean values for PHQ-9 at baseline and follow-up in the 2 groups (n=25 ICBT and n=25 DF). DF, discussion forum; ICBT, Internet-based
cognitive behavioral therapy; PHQ-9, Patient Health Questionnaire-9.
Secondary Outcomes: Cardiac-Related Anxiety and
QoL
Between group comparison (ie, ANCOVA, ICBT vs DF) showed
no statistically significant difference in the CAQ total score
[F(1,47)=0.51, P=.48], Cohen´s d= 0.18, subscale of fear [F (1,
47)=1.57, P=.22], Cohen´s d=0.43, subscale of avoidance
[F(1,47)=0.11, P=.74], Cohen´s d= 0.17, and subscale of
heart-focused attention [F(1,47)=0.39, P=.54], Cohen´s d= 0.08.
In the secondary within-group analysis, the ICBT group showed
a decrease in the total CAQ score and in the subscale of fear.
The decrease in the subscale of fear was statistically significant
(baseline M=1.55, SD=0.73 vs follow-up M=1.35, SD=0.60, t
(24)=2.18 P=.04. Cohen´s d=0.30), see Figure 3, but the
decrease in the total score was not significant (baseline M=1.60,
SD=0.58 vs follow-up M=1.49, SD=0.49, t (24)=1.25, P=.22.
Cohen´s d= 0.31). In the subscales of avoidance and
heart-focused attention, no significant changes were found
(Multimedia Appendix 3). In the DF group, no significant
changes in any of the CAQ scales were found (total P=.86, fear
P=.92, avoidance P=.82, heart-focused attention P=.83).
Between-group analysis (ie, ANCOVA, ICBT vs DF) of MLHF
revealed no significant differences for the total score [F
(1,47)=2.87, P=.09], Cohen´s d= 0.51, the physical factor [F
(1,47)=3.35, P=.07], Cohen´s d= 0.56, and the emotional factor
[F(1,47)=0.20, P=.66], Cohen´s d= 0.37. The change in scores
from baseline to the follow-up for the total score and the
physical and emotional factors in the MLHF is shown in
Multimedia Appendix 4. In the ICBT group, the mean total
score decreased by 6.0 points, by 2.4 points in the physical
factor and by 0.3 points in the emotional factor. None of the
differences were statistically significant; total score baseline
M=41.8, SD=20.5 vs follow-up M=35.8, SD=15.3, t (24)=1.79,
P=.09, Cohen´s d= 0.33; the physical factor, baseline M=17.5,
SD=8.7 vs follow-up M = 15.1, SD=7.5, t (24)=1.62, P=.12,
Cohen´s d= 0.28; baseline M=10.8, SD = 7.2 vs follow-up M
= 10.5, SD = 6.4, t (24)=0.31, P=.76, Cohen´s d= 0.05. In the
DF group, the mean total score decreased by 1.9 points, by 0.2
points in the physical factor, and by 0.8 points in the emotional
factor. None of the differences were significant; baseline
M=47.1, SD=24.0 vs follow-up M=45.3 SD=21.3, t (24)=0.64,
P=.53, Cohen´s d= 0.08; the physical factor baseline M=20.0,
SD=10.6 vs follow-up M = 19.8, SD=8.9, t (24)=0.14, P=.89,
Cohen´s d= 0.02; the emotional factor baseline M=13.7, SD =
6.3 vs follow-up M = 12.9, SD = 5.6, t (24)=0.91, P=.37,
Cohen´s d= 0.14.
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Figure 3. Change in cardiac anxiety—mean values for subscale of fear in the 2 groups (n=25 ICBT and n=25 DF). ANCOVA: [F(1,47)=1.57, P=.22],
total scale range for CAQ (mean values): 0-4. ANCOVA, analysis of covariance; CAQ, Cardiac Anxiety Questionnaire; DF, discussion forum; ICBT,
Internet-based cognitive behavioral therapy.
Relationship Between Factors and Changes in
Depressive Symptoms
The median number of modules performed in the ICBT group
was 4. Six (24%) of the participants in the ICBT group had
worked with all 7 modules and 15 (60%) had worked with at
least 4 modules (ie, 57% of the program). There was no
significant relationship between the number of modules
completed and the change in depressive symptoms (τb=.13,
P=.46). In the ICBT group, the number of logins to the Web
portal was significantly related to the change in depressive
symptoms (ie, improvement in depressive symptoms) (r=−.50,
P=.02) a similar relationship was found in the DF group
although not as strong and not significant (r=−.32, P=.17). Age
had a negative correlation with number of logins in the ICBT
group (r=−.67, P<.001). In the DF group, this correlation was
not so strong and not significant (r= −.24, P=.25).
The level of depressive symptoms at screening was not
associated with the level of depressive symptoms at the
follow-up. A separate analysis of participants with PHQ-9 ≥10
at screening (ICBT n=18, DF n=15) showed no significant
difference between groups in the level of depressive symptoms
at the follow-up [F (1,29)=1.30, P=.26] nor of participants with
PHQ-9 ≤15 (ICBT n=19, DF n=19) [F (1,34)=0.82, P=.37].
Higher age correlated significantly with less change in
depressive symptoms (r=.54, P=.01) in the ICBT group and
women (n=8, complete cases) (M = −3.4, SD=4.6) had a
significantly higher mean change in depressive symptoms
compared with men (n=13, complete cases) (M=−0.08, SD=2.6)
t (19)=2.12, P=.048. Cohen´s d= 0.89. The severity of HF as
assessed by NYHA class was not associated with a change in
depressive symptoms.
Discussion
Principal Findings
To our knowledge, this is the first study evaluating an ICBT
program aimed at decreasing depressive symptoms in patients
with HF. The recruitment of participants was more difficult than
expected. Based on a prevalence of depressive symptoms among
HF patients at approximately 20% [1], we expected about 571
of the 2852 contacted the patients have a significant level of
depressive symptoms. However, only 80 patients registered as
interested and 50 were found to be eligible for inclusion. Other
studies of CBT in HF also appear to have difficulty in achieving
sample sizes corresponding to power analysis [14,15,33]. Due
to practical and economic reasons, we chose to end the study
without achieving the targeted sample size. Other recruitment
strategies may be more effective. However, there may also be
a structural problem in reaching out to patients with HF and
depressive symptoms. This is because depressive symptoms
can reduce patients’ decision-making process due to
ambivalence and impaired cognitive functioning [34]. Our
primary analysis could not detect any significant difference in
the reduction of depressive symptoms between the ICBT and
DF groups; this may be explained by the slight reduction of
depressive symptoms in the DF group. Dekker et al [35] reported
similar results where depressive symptoms decreased in HF
patients who received a brief CBT intervention or received
standard care before discharge from hospital. The within-group
analysis of depressive symptoms showed a significant decrease
in the ICBT group but not in the DF group. These findings are
in line with previous studies reporting that CBT for depression
is significantly superior compared with no treatment, but only
nominally superior compared with psychological placebo [33,36]
such as the DF in our study. Studies specifically on HF patients
with depressive symptoms also suggest that an active
intervention, such as CBT or placebo with attention control such
as DF can reduce depressive symptoms to a greater extent than
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standard care [14,15,37]. Designing a new ICBT program is a
complex process [38]. Our program is to our knowledge one of
the first ICBT programs for patients with HF and depressive
symptoms. Furthermore, HF patients are often older compared
with other patient groups treated with ICBT. Therefore, there
is a need for more research to gain knowledge on how to design
or redesign ICBT programs for the HF population. A possible
future approach to achieve optimal results in treatment of
depressive symptoms in HF could be a stepped care model [39]
where patients could start with a type of DF or physical exercise,
and if the depressive symptoms did not improve, ICBT could
be added. However, such models have to be evaluated in further
studies.
The secondary outcomes of CAQ and MLHF did not show any
significant difference between the ICBT group and the DF
group. However, in the ICBT group, a lower cardiac-related
anxiety in the subscale of fear and an increased QoL was found
in the within-group analysis. The increase in QoL of 6 points
in the total MLHF score was not statistically significant;
however, a change of 5 points in MLHF has been proposed as
a measure of a clinically important change [30].
It is common for depressive symptoms in patients with HF to
coexist with anxiety [11]. Anxiety CBT treatment can have a
better effect on depressive symptoms than CBT for depression
in patients with HF [40]. Thus, anxiety and worries may need
special attention when designing or redesigning ICBT
interventions for patients with HF and depressive symptoms.
We also found that the age and sex of the participant may need
to be taken into account. Higher age and male sex correlated
with less change in depressive symptoms in the ICBT group.
Older people to some extent seem to benefit from CBT [20,41];
however, the evidence of benefit for them is greater in
problem-solving therapy [42,43]. Our ICBT program relied to
a large extent on behavioral activation and to a lesser extent on
problem-solving therapy [20]. Most patients with HF are older
and vulnerable, which raises an important question of whether
problem-solving therapy should be used to a greater extent in
future studies, as proposed by Alexopoulos et al [44]. Women
showed more positive effects compared with men in the ICBT
group. This is in line with the results of other ICBT studies
[45,46]. However, sex as a predictor of outcome of CBT
delivered by other modalities has shown inconsistent results;
men have been reported to have a better response in telephone
and face-to-face CBT [47]. More research is needed to determine
whether CBT and ICBT should be adapted to the different sexes.
The cornerstone of CBT is to encourage participants and involve
them in the treatment [48]. We found that activity in the
program, as indicated by the number of logins, correlated
significantly with a change in depressive symptoms. This
suggests that helping participants in ICBT programs to be active
is important for a positive outcome. In our program, participants
who did not follow the pace of the program were reminded to
do so by email. In contrast, others have used more intensive
reminder techniques of both text messages and phone calls, and
thereby achieved a higher adherence to ICBT treatment [49,50].
This indicates that more direct reminders can motivate less
active participants. The number of modules performed did not
correlate with level of depression at follow-up. The reasons for
this have not been investigated in this study. However, during
the study, we experienced that some patients early in the
program reported that they felt better and therefore did not
proceed with the next module. This may have affected the result
negatively, thus one may speculate that patients might have
improved even more if they had completed the program. Our
study has shown that ICBT for HF patients with depressive
symptoms is feasible. However, further research is needed to
develop effective ICBT programs for depressive symptoms in
HF patients. Furthermore, this study only evaluated the effect
directly after the intervention; thus, the long-term effects of
ICBT on depression in patients with HF need to be evaluated
in future studies.
The generalizability of the results is limited for several reasons.
One major limitation of our study is that it is underpowered.
Post hoc power calculation for this study showed a power of
16% and a need for 462 patients to be included to achieve a
statistically significant result as regards depressive symptoms.
A reason for the need for such a large sample could be floor
effects, because patients with mild depression were also included
(PHQ-9≥5). A reason for including these patients is that even
mild depression has a strong negative impact on QoL in HF
patients [51]. The mean age in the study sample was lower
compared with the HF population in the community
(approximately 78 years) [52]; thus, it is unclear how the
program works in older HF patients. Furthermore, the study
could only include patients with access to a computer and the
Internet, and therefore, the results cannot be generalized to
patients without such access. On the other hand, in Sweden,
42% (n=355 793) of the population aged older than 75 years
use computers and the Internet at home. This figure is expected
to rise to approximately 80% in the coming 5-10 years [53].
There is a potential limitation in relying on self-reported data.
However, all patients were identified by diagnostic codes for
HF from electronic hospital records and were contacted by
telephone to verify their reported medication and comorbidities.
There were twice as many participants taking an antidepressant
medication in the DF group compared with the ICBT group.
The reason for this not being statistically significant is probably
due to low power in the study. Subgroup analysis in this study
has to be interpreted with caution due to the limited sample size.
Missing data were imputed using the EM method. Although
Littles´ test indicated that the missing data in our study appear
to be missing at random, this can never be certain, and missing
data and imputation can carry a risk of bias. Initially, all analysis
was performed on both nonimputed data and imputed data, and
we found no significant differences between the analysis with
the exception of the ANCOVA on the physical factor of QoL,
which presented a significant difference between the groups on
nonimputed data but not on imputed data. There were more
patients reporting use of antidepressive medication
(nonsignificant) and sleep medication (significant) in the DF
group. We do not think that this had any major impact on our
result. For example, pharmacological antidepressive treatment
in HF patients has shown a poor effect on depression [37]. The
lack of power of this study may also have resulted in differences
not being detected between participants completing the
intervention and dropouts. Nevertheless, we think that our study
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is important since interventions for patients with HF and
depressive symptoms are not widely studied. To our knowledge,
our study is one of the first to investigate the effect of ICBT in
HF and depressive symptoms. Development of new interventions
is an iterative process [38] and although clear-cut results may
be desirable, the novelty of the research area makes this unlikely.
With our study’s limited sample size and its recruitment
difficulties, the results may best serve as a foundation for further
research rather than as clinical recommendations.
Conclusion
Guided ICBT adapted for persons with HF and depressive
symptoms was not statistically superior to participation in a
Web-based DF. However, within the ICBT group, a statically
significant improvement of depressive symptoms was detected.
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